JMML patient-derived iPSCs induce new hypotheses

Blood

Volumn 121, Issue 24, 2013, Pages 4815-4817

  Chan, Rebecca J ^a   Yoder, Mervin C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; CD18 ANTIGEN; CD45 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; N RAS PROTEIN; NF1 PAROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAF PROTEIN; RAS PROTEIN; STAT5 PROTEIN; UNCLASSIFIED DRUG; PROTEIN TYROSINE PHOSPHATASE 1B; PTPN1 PROTEIN, HUMAN;

ALLOGENEIC STEM CELL TRANSPLANTATION; BONE MARROW CELL; CANCER SURVIVAL; CELL CLONING; GAIN OF FUNCTION MUTATION; HEMATOPOIETIC CELL; HUMAN; INDUCED PLURIPOTENT STEM CELL; JUVENILE MYELOMONOCYTIC LEUKEMIA; LOSS OF FUNCTION MUTATION; MACROPHAGE; MYELOID PROGENITOR CELL; NONHUMAN; NOTE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOMATIC MUTATION; WILD TYPE; CANCER STEM CELL; FEMALE; MALE; METABOLISM; MISSENSE MUTATION; PLURIPOTENT STEM CELL;

FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; MALE; MUTATION, MISSENSE; NEOPLASTIC STEM CELLS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1;

MLCS; MLOWN;

EID: 84881291273     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-05-500090     Document Type: Note

References (10)

1. Gandre-Babbe S, Paluru P, Aribeana C, et al. Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia. Blood. 2013;121(24):4925-4929.
2. Nabinger SC, Chan RJ. Shp2 function in hematopoietic stem cell biology and leukemogenesis. Curr Opin Hematol. 2012;19(4):273-279.
3. Loh ML. Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Br J Haematol. 2011;152(6):677-687.
4. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood. 1991;77(5):925-929.
5. Ward AF, Braun BS, Shannon KM. Targeting oncogenic Ras signaling in hematologic malignancies. Blood. 2012;120(17):3397-3406.
6. Yoshimoto M, Yoder MC. Developmental Hematopoiesis. In: Broxmeyer HE, ed. Cord Blood: Biology, Transplantation, Banking and Regulation. Bethesda, MD: AABB Press; 2011:17-34.
7. Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330(6005):841-845.
8. Schulz C, Gomez Perdiguero E, Chorro L, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012;336(6077):86-90.
9. Cherry AB, Daley GQ. Reprogrammed cells for disease modeling and regenerative medicine. Annu Rev Med. 2013;64:277-290.
10. Psaltis PJ, Harbuzariu A, Delacroix S, et al. Identification of a monocyte-predisposed hierarchy of hematopoietic progenitor cells in the adventitia of postnatal murine aorta. Circulation. 2012;125(4):592-603.